Insider Transactions

NEWMONT Corp /DE/ (NEM) Insider Transactions

Over the last 12 months, 22 NEWMONT Corp /DE/ (NEM) insiders filed 85 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $10.4M in open-market sales. 7% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 85 (1-year window)

Each row is a single Form 4 filing event for NEM, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-06-01 Viljoen Natascha President & CEO Sell 10b5-1 S $408.9K 3,882 $105.32
2026-06-01 Toth Peter EVP, Chief Sustain & Dev Off Sell 10b5-1 S $316.0K 3,000 $105.32
2026-05-14 Leyva Deborah Interim Chief People Officer Grant A $0 1,938 $0.00
2026-05-13 Layman Sally-Anne Grant A $0 1,645 $0.00
2026-05-13 Seaton David Thomas Grant A $0 1,645 $0.00
2026-05-13 Quintana Julio M Grant A $0 1,645 $0.00
2026-05-13 Nelson Jane Grant A $0 1,645 $0.00
2026-05-13 Medori Rene Grant A $0 1,645 $0.00
2026-05-13 FitzGerald Emma Grant A $0 1,645 $0.00
2026-05-13 Conger Harry M. IV Grant A $0 1,645 $0.00
2026-05-13 CLARK MAURA J Grant A $0 1,645 $0.00
2026-05-13 Brook Bruce R Grant A $0 1,645 $0.00
2026-05-13 BOYCE GREGORY H Grant A $0 1,719 $0.00
2026-05-13 Madero Garza Jose Manuel Grant A $0 1,645 $0.00
2026-05-01 Thornton David John MD, Americas Sell 10b5-1 S $252.8K 2,296 $110.11
2026-05-01 Wexler Peter EVP, CLO & Interim CFO Sell 10b5-1 S $1.5M 13,378 $110.11
2026-05-01 Toth Peter EVP, Chief Sustain & Dev Off Sell 10b5-1 S $330.3K 3,000 $110.11
2026-04-30 Thornton David John MD, Americas Other F $194.2K 1,805 $107.61
2026-04-30 Wexler Peter EVP, CLO & Interim CFO Other F $617.9K 5,742 $107.61
2026-04-30 Wexler Peter EVP, CLO & Interim CFO Other F $502.1K 4,666 $107.61
2026-04-01 Toth Peter EVP, Chief Sustain & Dev Off Sell 10b5-1 S $339.3K 3,000 $113.09
2026-03-18 Toth Peter EVP, Chief Sustain & Dev Off Sell $324.0K 3,000 $108.00
2026-03-16 Fry David James Group Head Projects & Studies Sell $2.1M 18,394 $111.45
2026-03-03 Rodgers Mark C MD, Africa-Asia Pacific Sell $164.4K 1,361 $120.78
2026-03-03 Thornton David John MD, Americas Sell $973.5K 8,060 $120.78
2026-03-02 Tabolt Brian SVP & CAO Grant $27.4K 215 $127.47
2026-03-02 Cmil Jennifer EVP and Chief People Officer Grant $113.8K 893 $127.47
2026-03-02 Thornton David John MD, Americas Grant $76.4K 599 $127.47
2026-03-02 Hardy Francois EVP & CTO Grant $95.0K 745 $127.47
2026-03-02 Toth Peter EVP, Chief Sustain & Dev Off Grant $148.0K 1,161 $127.47
2026-03-02 Thornton David John MD, Americas Sell $123.8K 944 $131.14
2026-03-02 Rodgers Mark C MD, Africa-Asia Pacific Sell $269.0K 2,051 $131.14
2026-02-27 Tabolt Brian SVP & CAO Grant $0 490 $0.00
2026-02-27 Cmil Jennifer EVP and Chief People Officer Grant $0 2,041 $0.00
2026-02-27 Thornton David John MD, Americas Grant $0 1,361 $0.00
2026-02-27 Hardy Francois EVP & CTO Grant $0 1,701 $0.00
2026-02-27 Toth Peter EVP, Chief Sustain & Dev Off Grant $0 2,653 $0.00
2026-02-27 Rodgers Mark C MD, Africa-Asia Pacific Grant $0 1,361 $0.00
2026-02-27 Fry David James Group Head Projects & Studies Grant $0 817 $0.00
2026-02-27 Hardy Francois EVP & CTO Grant $178.8K 1,403 $127.47
2026-02-27 Tabolt Brian SVP & CAO Grant $154.5K 1,212 $127.47
2026-02-27 Thornton David John MD, Americas Grant $143.9K 1,129 $127.47
2026-02-27 Toth Peter EVP, Chief Sustain & Dev Off Grant $278.9K 2,188 $127.47
2026-02-27 Cmil Jennifer EVP and Chief People Officer Grant $214.5K 1,683 $127.47
2026-02-27 Rodgers Mark C MD, Africa-Asia Pacific Sell $577.6K 4,443 $130.00
2026-02-26 Hardy Francois EVP & CTO Grant $400.3K 3,206 $124.85
2026-02-26 Tabolt Brian SVP & CAO Grant $250.3K 2,005 $124.85
2026-02-26 Thornton David John MD, Americas Grant $239.8K 1,921 $124.85
2026-02-26 Toth Peter EVP, Chief Sustain & Dev Off Grant $414.6K 3,321 $124.85
2026-02-26 Viljoen Natascha President & CEO Grant $650.2K 5,208 $124.85

Showing the most recent 50 of 85 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track NEM Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for NEWMONT Corp /DE/?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of NEWMONT Corp /DE/ (NEM) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of NEWMONT Corp /DE/ (NEM) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.